Literature DB >> 12121666

Salp15, an ixodes scapularis salivary protein, inhibits CD4(+) T cell activation.

Juan Anguita1, Nandhini Ramamoorthi, Joppe W R Hovius, Subrata Das, Venetta Thomas, Rafal Persinski, Dietrich Conze, Philip W Askenase, Mercedes Rincón, Fred S Kantor, Erol Fikrig.   

Abstract

Tick saliva has pleiotropic properties that facilitate persistence of the arthropod upon the host. We now describe a feeding-inducible protein in Ixodes scapularis saliva, Salp15, that inhibits CD4(+) T cell activation. The mechanism involves the repression of calcium fluxes triggered by TCR ligation and results in lower production of interleukin-2. Salp15 also inhibits the development of CD4(+) T cell-mediated immune responses in vivo, demonstrating the functional importance of this protein. Salp15 provides a molecular basis for understanding the immunosuppressive activity of I. scapularis saliva and vector-host interactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121666     DOI: 10.1016/s1074-7613(02)00325-4

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  96 in total

1.  The tick saliva immunosuppressor, Salp15, contributes to Th17-induced pathology during Experimental Autoimmune Encephalomyelitis.

Authors:  Ignacio J Juncadella; Tonya C Bates; Reem Suleiman; Andrea Monteagudo-Mera; Chris M Olson; Nicolás Navasa; Elias R Olivera; Barbara A Osborne; Juan Anguita
Journal:  Biochem Biophys Res Commun       Date:  2010-11-05       Impact factor: 3.575

2.  Deconstructing tick saliva: non-protein molecules with potent immunomodulatory properties.

Authors:  Carlo José F Oliveira; Anderson Sá-Nunes; Ivo M B Francischetti; Vanessa Carregaro; Elen Anatriello; João S Silva; Isabel K F de Miranda Santos; José M C Ribeiro; Beatriz R Ferreira
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

Review 3.  Tick saliva in anti-tick immunity and pathogen transmission.

Authors:  L Kovár
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

4.  Differential salivary gland transcript expression profile in Ixodes scapularis nymphs upon feeding or flavivirus infection.

Authors:  Kristin L McNally; Dana N Mitzel; Jennifer M Anderson; José M C Ribeiro; Jesus G Valenzuela; Timothy G Myers; Alvaro Godinez; James B Wolfinbarger; Sonja M Best; Marshall E Bloom
Journal:  Ticks Tick Borne Dis       Date:  2012-01-02       Impact factor: 3.744

5.  Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15.

Authors:  Renu Garg; Ignacio J Juncadella; Nandhini Ramamoorthi; Shobana K Ananthanarayanan; Venetta Thomas; Mercedes Rincón; Joanna K Krueger; Erol Fikrig; Christopher M Yengo; Juan Anguita
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

6.  The Ixodes scapularis salivary protein, salp15, prevents the association of HIV-1 gp120 and CD4.

Authors:  Ignacio J Juncadella; Renu Garg; Tonya C Bates; Elias R Olivera; Juan Anguita
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

7.  Inhibition of neutrophil function by two tick salivary proteins.

Authors:  Xiuyang Guo; Carmen J Booth; Michael A Paley; Xiaomei Wang; Kathleen DePonte; Erol Fikrig; Sukanya Narasimhan; Ruth R Montgomery
Journal:  Infect Immun       Date:  2009-03-30       Impact factor: 3.441

8.  Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection.

Authors:  Eric H Weening; Nikhat Parveen; Jerome P Trzeciakowski; John M Leong; Magnus Höök; Jonathan T Skare
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

Review 9.  Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector.

Authors:  Faith Kung; Juan Anguita; Utpal Pal
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

Review 10.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.